Cargando…
Proteome profiling of clear cell renal cell carcinoma in von Hippel-Lindau patients highlights upregulation of Xaa-Pro aminopeptidase-1, an anti-proliferative and anti-migratory exoprotease
Patients of the von Hippel-Lindau (VHL) disease frequently develop clear cell renal cell carcinoma (ccRCC). Using archived, formalin-fixed, paraffin-embedded (FFPE) samples, we sought to determine global proteome alterations that distinguish ccRCC tissue from adjacent, non-malignant kidney tissue in...
Autores principales: | Drendel, Vanessa, Heckelmann, Bianca, Chen, Chia-Yi, Weisser, Juliane, Espadas, Guadalupe, Schell, Christoph, Sabido, Eduard, Werner, Martin, Jilg, Cordula A., Schilling, Oliver |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725003/ https://www.ncbi.nlm.nih.gov/pubmed/29245961 http://dx.doi.org/10.18632/oncotarget.21929 |
Ejemplares similares
-
Proteomic distinction of renal oncocytomas and chromophobe renal cell carcinomas
por: Drendel, Vanessa, et al.
Publicado: (2018) -
Hemangioblastoma and von Hippel-Lindau disease: genetic background, spectrum of disease, and neurosurgical treatment
por: Klingler, Jan-Helge, et al.
Publicado: (2020) -
Growth characteristics and therapeutic decision markers in von Hippel-Lindau disease patients with renal cell carcinoma
por: Schuhmacher, Patrick, et al.
Publicado: (2019) -
Von Hippel-Lindau Disease
por: Hes, Frederik J, et al.
Publicado: (2005) -
Stereotactic Body Radiotherapy for Renal Cell Carcinoma in Patients with Von Hippel–Lindau Disease—Results of a Prospective Trial
por: Kirste, Simon, et al.
Publicado: (2022)